Replies to post #703 on Vascular Biogenics Ltd (VBLT)

[Oren1976]

This what will happen. We will.have to be patient. The interim analysis will be delayed to such an extent that they announce the end of the trial with substantial success. Ovarian cancer phase 3 if it will be design same as the ph2 they will pass easily. I don't think in August September they announce they continue the trial. It will be stopped - there are no surprises in drugs. A drug that double os should show the benefits clearly in August September

[Oren1976]

252 patients in trial. What if 109 death happen only in March 2018 . Don't tell me it's not possible. I think there is atleast 20% it's possible.